Here, we used mice carrying a mutated, inactivated PAR2 (PAR2 knockout (PAR2KO)),8 and pharmacological activator to show that PAR2 was necessary and sufficient for islet cell transdifferentiation induction in the setting of β-cell deficiency. The gene discussed is F2RL1; the disease is B cell deficiency.